«Case study reveals therapy to reduce sarcoidosis symptoms in 5q - myelodysplastic syndrome: Use of lenalidomide in 5q -
myelodysplastic syndrome provides new hope in sarcoidosis therapy.»
The entire study «Use of Lenalidomide in 5q -
Myelodysplastic Syndrome Provides Novel Treatment Prospects in Management of Pulmonary Sarcoidosis» can be viewed in the August issue of CHEST.